23 Jul, 2026
According to Straits Research, the global medical ceramics market valued at $21.11 billion in 2025, is projected to grow from $22.45 billion in 2026 to $36.67 billion by 2034 at a CAGR of 6.33% during the forecast period 2026–2034.
Medical-grade ceramics are frequently utilized in applications such as the creation of prosthetics, implants, and medical instruments and devices. Medical applications of ceramics include the repair or replacement of musculoskeletal connective tissues. They are also used in orthopedic implants, dental implants, and bone screws.
The rise in the number of medical procedures caused by the prevalence of chronic diseases is driving the expansion of the market for medical ceramics. Globally accessible ceramic implants include dental implants, orthopedic implants, and implantable electronic devices. In addition, the growing number of medical implants contributes to the expansion of the market. Composite materials such as hydroxy appetite (HAP) and zirconia are the market's most lucrative investment opportunities. Factors such as the increasing desire for less invasive medical procedures and the launch of innovative products to improve the efficacy of therapeutic and diagnostic medical procedures have contributed to the rise in medical operations. Consequently, the rising number of medical procedures utilizing medical ceramics is anticipated to fuel the growth of the worldwide medical ceramics market over the study period.
The market is growing due to the incorporation of ceramics into medical equipment, the aging population that requires implant procedures, and government initiatives to research medical ceramics. Competitors in the market for medical ceramics supply excellent, technologically sophisticated items and well-regulated customer service activities. In addition, many market leaders are employing strategies such as acquisitions and mergers to extend their product range by launching new goods and partnering with more minor industry leaders. For instance, Friatec GmbH ("Friatec"), a German manufacturer and supplier of ceramic and plastic components, acquired the advanced Kyocera medical ceramics business operations of Kyocera Fineceramics GmbH via a newly established subsidiary, according to a May 2019 announcement from Kyocera Corporation.
North America is the most significant shareholderand is anticipated to grow at a CAGR of 6.12% during the forecast period. The high incidence of tooth decay, rising injuries, and the quick uptake of medical ceramics in the medical device market are all contributing factors to the Americas having the most significant market share. As per the American Dental Association, Health Policy Resources Center, Supply of Dentists, 2017, more than 3,500 practicing prosthodontists and prosthodontic residents are in the US. More than 36 million US residents do not have teeth, while 120 million are missing at least one tooth. These numbers are expected to increase in the next two decades. The region's strong demand for dental services and ample supply of dental experts are anticipated to expand the market.
Europe is expected to growat a CAGR of 5.70% over the forecast period. Due to an increase in patients and the availability of products in the region, Europe is predicted to have considerable growth over the projection period. Medical ceramics are used for manufacturing surgical implants, prosthetics, and various medical tools and devices. The nations in the region with the most hip and knee replacements in 2017 included Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium. In most OECD nations, hip and knee replacements have quickly climbed since 2000. Additionally, the average number of hip and knee replacements increased by 30% and 40%, respectively, between 2007 and 2017. This increase in the number of patients undergoing knee replacement is anticipated to boost the regional market's growth. Further, the availability of ceramic implants in the market has increased, especially since established implant companies such as Camlog (Ceralog), Straumann (Pure and Snow), and Nobel Biocare (Nobel Pearl) have each added zirconia implants to their product portfolios.
sales@straitsresearch.com